July 25, 2014

Cover Story

CEO of the Year

Utah’s business landscape is rich with professionals who have le...Read More

Featured Articles

Did you go Skiing this winter?

Around Utah

Sections

Spotlight
Martin Plaehn

Spotlight
Karen Sendelback

Legal Briefs
Social Media and Employers: Friends or Enemies?

Money Talk
The Case for HSAs

Economic Insight
Time to Show Up

Lessons Learned
Make a Move

TechKnowledge
In the Lab

EntrepreneurEdge
Rent to Own

Business Trends
Back from the Dead

Living Well
Artful Inspiration

Features
A Breath of Fresh Air

Features
Worst-Case Scenario

Regional Report
Northern Utah

Focus
Measure Up

Industry Outlook
Travel & Tourism

Players
Players

Article

BioFire Diagnostics Begins Clinical Trials of ME Panel

Press Release

July 25, 2014

Salt Lake City – BioFire Diagnostics, LLC, bioMérieux’s molecular biology affiliate, has commenced clinical and analytical studies to evaluate the company’s FilmArray meningitis/encephalitis (ME) panel, with plans to seek both FDA clearance and CE IVD marking.

Infection of the meninges surrounding the brain and spinal cord (meningitis), or of the brain (encephalitis) can have high mortality and morbidity rates depending on the source of infection. Acute bacterial meningitis is a rare, but potentially fatal disease. Conversely, viral meningitis is more common, but typically mild and non-lethal. However, clinical diagnosis of the meningitis syndrome is difficult since their signs and symptoms are virtually indistinguishable. With a run time of about an hour, the comprehensive ME panel requires only 200 microliters of cerebrospinal fluid to test simultaneously for 16 different bacterial, viral, and fungal pathogens known to cause community-acquired meningitis and encephalitis.

“The commencement of studies to evaluate our meningitis test is exciting since the FilmArray has the potential to make a profound impact on treating this fatal disease, where symptoms can appear suddenly and escalate quickly,” said Randy Rasmussen, bioMérieux Corporate vice president of molecular biology and CEO of BioFire Diagnostics.

The clinical study is being conducted at several hospital-based clinical laboratories in the U.S. BioFire expects the FDA submission in 2015. The ME panel will be the fourth clinical diagnostic test to run on the FilmArray System.

Additionally, BioFire will exhibit the FilmArray at booth 1257 during the 2014 American Association of Clinical Chemistry (AACC) annual meeting July 29-31 in Chicago.

 

Utah Business Social
UB Events View All
CEO of the YearUtah Business Event
Mar 20, 2015
Utah Business Magazine and Presenting Sponsors - Holland & Hart and Newmark Grubb ACRES - are pro...
Job Summit 2015Utah Business Event
Apr 10, 2015
Position your company as a Premier Employer in today's competitive job market! Utah Business maga...
30 Women to WatchUtah Business Event
May 21, 2015
Utah Business magazine and Snell and Wilmer are proud to announce the 18th annual 30 Women To Wat...
Community Events View All
Advance Your HR Career by Building Credibility, Trust, and Professionalism
Mar 3, 2015
Even if you know your craft, do you know how to improve others’ perception of your ability and pr...
CEH - Certified Ethical Hacker
Mar 3, 2015
Learn to hack like a pro, while pleasing the boss! The ethical hacker is usually a trusted employ...

info@utahbusiness.com  |  90 South 400 West, Ste 650 Salt Lake City, Utah 84101   |  (801) 568-0114

Advertise with Utah Business

Submit an Event

* indicates required information
* Event Name:
Price (general):
Website (if applicable):
Coordinator's Name:
Coordinator's Email:
Coordinator's Phone:
Venue Name:
Venue Address:
Venue City:
Venue Zip:
Event Capacity:
Date(s):
to
* Event Description:
  Cancel